Showing results (31-40 of 105) with videos related to
Sort By:
Pageof 11
Pharmaceuticals (Basel, Switzerland)|July 17, 2020
Safety of Repeated Administration of Parenteral Ketamine for DepressionDavid Feifel, David Dadiomov, Kelly C LeeJournal of Trauma & Dissociation : the Official Journal of the International Society for the Study of Dissociation (ISSD)|October 13, 2009
Peas, please: a case report and neuroscientific review of dissociative amnesia and fugueKai MacDonald, Tina MacDonaldInnovations in Clinical Neuroscience|June 30, 2016
WHY NOT POT?: A Review of the Brain-based Risks of CannabisKai MacDonald, Katherine PappasPsychiatry (Edgmont (Pa. : Township))|April 30, 2010
Daytrana: the first yearElisa F Cascade, Amir H Kalali, David FeifelEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 4, 2011
The effects of oxytocin and its analog, carbetocin, on genetic deficits in sensorimotor gatingDavid Feifel, Paul D Shilling, Annabelle M BelcherPsychiatry (Edgmont (Pa. : Township))|September 4, 2009
Treatment of autistic childrenElisa F Cascade, Amir H Kalali, David FeifelPsychiatry (Edgmont (Pa. : Township))|August 17, 2010
Strattera: ups, downs, and emerging usesElisa F Cascade, Amir H Kalali, David FeifelPsychiatry (Edgmont (Pa. : Township))|September 4, 2009
Use of risperidone long-acting injectable in a rural border community clinic in southern californiaAlvaro Camacho, Bernardo Ng, Barbara Galangue, et al.Journal of Affective Disorders|July 1, 2017
Low-dose ketamine for treatment resistant depression in an academic clinical practice settingDavid Feifel, Benjamin Malcolm, Danielle Boggie, et al.Harvard Review of Psychiatry|January 6, 2010
The peptide that binds: a systematic review of oxytocin and its prosocial effects in humansKai Macdonald, Tina Marie MacdonaldPageof 11